Nasonex and Odefsey drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasonex (mometasone furoate monohydrate) and Odefsey (emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate). Common drug interactions include anxiety among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Nasonex and Odefsey. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Nasonex?

Nasonex has active ingredients of mometasone furoate monohydrate. It is often used in allergies. eHealthMe is studying from 32,299 Nasonex users. Check the latest studies of Nasonex.

What is Odefsey?

Odefsey has active ingredients of emtricitabine; rilpivirine hydrochloride; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 4,605 Odefsey users. Check the latest studies of Odefsey.

On Jul, 05, 2026

24 people who take Nasonex and Odefsey together, and have interactions are studied.

What are the common drug interactions of Nasonex and Odefsey, by gender? *:

female:

Anxiety
Bone density decreased
Emotional distress
Pain
Depression
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Arthralgia (joint pain)
Osteoporosis (bones weak and more likely to break)
Gait disturbance
Nightmare (unpleasant dream)

male:

Emotional distress
Pain
Osteoporosis (bones weak and more likely to break)
Skeletal injury (bone and supporting muscle injury)
Nephropathy (damage to or disease of a kidney)
Abdominal discomfort
Abnormal dreams
Blood creatinine increased
Blood glucose increased
Bone disorder

What are the common drug interactions of Nasonex and Odefsey, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Anxiety
Bone density decreased
Depression
Emotional distress
Osteopenia (a condition where bone mineral density is lower than normal)
Pain
Arthralgia (joint pain)
Osteonecrosis (death of bone)

40-49:

Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Emotional distress
Pain
Bone density decreased
Bone loss
Multiple fractures
Osteoporosis (bones weak and more likely to break)
Abdominal discomfort
Abnormal dreams

50-59:

Emotional distress
Pain
Mobility decreased (ability to move is reduced)
Multiple fractures
Necrosis (the death of body tissue)
Osteoporosis (bones weak and more likely to break)
Renal failure (kidney dysfunction)
Arthralgia (joint pain)
Back pain
Blood creatinine increased

60+:

n/a

What are the existing conditions these people have? *

Pain: 3 people, 12.50%
Hypersensitivity: 3 people, 12.50%
Rashes (redness): 2 people, 8.33%
Pain In Extremity: 2 people, 8.33%
Indigestion: 2 people, 8.33%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Nasonex and Odefsey?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously